DK396381A - Faste laegemiddelpraeparater og fremgangsmaade til deres fremstilling - Google Patents

Faste laegemiddelpraeparater og fremgangsmaade til deres fremstilling

Info

Publication number
DK396381A
DK396381A DK396381A DK396381A DK396381A DK 396381 A DK396381 A DK 396381A DK 396381 A DK396381 A DK 396381A DK 396381 A DK396381 A DK 396381A DK 396381 A DK396381 A DK 396381A
Authority
DK
Denmark
Prior art keywords
procedures
preparation
pharmaceutical preparations
solid pharmaceutical
solid
Prior art date
Application number
DK396381A
Other languages
English (en)
Other versions
DK154326B (da
DK154326C (da
Inventor
A Hegasy
K D Raemsch
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6111496&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK396381(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of DK396381A publication Critical patent/DK396381A/da
Publication of DK154326B publication Critical patent/DK154326B/da
Application granted granted Critical
Publication of DK154326C publication Critical patent/DK154326C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
DK396381A 1980-09-09 1981-09-08 Fremgangsmåde til fremstilling af faste Nifedipin--præparater med langvaring virkning DK154326C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19803033919 DE3033919A1 (de) 1980-09-09 1980-09-09 Feste arzneizubereitungen enthaltend nifedipin und verfahren zu ihrer herstellung
DE3033919 1980-09-09

Publications (3)

Publication Number Publication Date
DK396381A true DK396381A (da) 1982-03-10
DK154326B DK154326B (da) 1988-11-07
DK154326C DK154326C (da) 1995-03-13

Family

ID=6111496

Family Applications (1)

Application Number Title Priority Date Filing Date
DK396381A DK154326C (da) 1980-09-09 1981-09-08 Fremgangsmåde til fremstilling af faste Nifedipin--præparater med langvaring virkning

Country Status (20)

Country Link
EP (1) EP0047899B2 (da)
JP (1) JPS5914446B2 (da)
AR (1) AR226377A1 (da)
AT (1) ATE5761T1 (da)
AU (1) AU558331B2 (da)
CA (1) CA1180277A (da)
DD (1) DD201974A5 (da)
DE (2) DE3033919A1 (da)
DK (1) DK154326C (da)
FI (1) FI72648B (da)
GR (1) GR78237B (da)
HU (1) HU184879B (da)
IE (1) IE51549B1 (da)
IL (1) IL63749A (da)
NO (1) NO157368B (da)
NZ (1) NZ198285A (da)
PH (1) PH24097A (da)
PL (1) PL232951A1 (da)
PT (1) PT73603B (da)
ZA (1) ZA816213B (da)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264446A (en) * 1980-09-09 1993-11-23 Bayer Aktiengesellschaft Solid medicament formulations containing nifedipine, and processes for their preparation
JPS5846019A (ja) * 1981-09-14 1983-03-17 Kanebo Ltd 持続性ニフエジピン製剤
DE3222367A1 (de) * 1982-06-15 1983-12-15 Bayer Ag, 5090 Leverkusen Verwendung von 1,4-dihydropyridinen in antiarteriosklerotika und deren herstellung
JPS59101423A (ja) * 1982-12-02 1984-06-12 Takada Seiyaku Kk 新規なニフエジピン固形製剤
US4529733A (en) * 1983-04-06 1985-07-16 Merrell Dow Pharmaceuticals Inc. Antihypertensive 3-furoyl-1,4-dihydropyridines
DE3318649A1 (de) * 1983-05-21 1984-11-22 Bayer Ag, 5090 Leverkusen Zweiphasenformulierung
HU198844B (en) * 1984-06-14 1989-12-28 Sandoz Ag Process for producing new galenic pharmaceutical composition ensuring retarded release of active ingredient
IT1178511B (it) * 1984-09-14 1987-09-09 Pharmatec Spa Procedimento per la preparazione di una forma solida per uso orale a base di nifedipina con rilascio
IT1187751B (it) * 1985-10-15 1987-12-23 Eurand Spa Procedimento per la preparazione di formulazioni solidi di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute
US4940556A (en) * 1986-01-30 1990-07-10 Syntex (U.S.A.) Inc. Method of preparing long acting formulation
US5198226A (en) * 1986-01-30 1993-03-30 Syntex (U.S.A.) Inc. Long acting nicardipine hydrochloride formulation
CH673947A5 (da) * 1986-09-23 1990-04-30 Sandoz Ag
JPS6464659A (en) * 1987-09-03 1989-03-10 Kenbi Kogaku Kenkyusho Kk Preparation of safe and effective powder formulation
SE8703881D0 (sv) * 1987-10-08 1987-10-08 Haessle Ab New pharmaceutical preparation
DE3814532A1 (de) * 1988-04-29 1989-11-09 Bayer Ag Dhp-retard-zubereitung
JPH0298550U (da) * 1989-01-25 1990-08-06
GB8903328D0 (en) * 1989-02-14 1989-04-05 Ethical Pharma Ltd Nifedipine-containing pharmaceutical compositions and process for the preparation thereof
US5271944A (en) * 1991-04-05 1993-12-21 Biofor, Ltd. Pharmacologically enhanced formulations
DE4130173A1 (de) * 1991-09-11 1993-03-18 Bayer Ag Pharmazeutische zubereitungen mit einer speziellen kristallmodifikation des 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridindicarbonsaeure-isopropyl-(2-methoxyethyl)-esters
GB9200607D0 (en) * 1992-01-13 1992-03-11 Ethical Pharma Ltd Pharmaceutical compositions containing nifedipine and process for the preparation thereof
US5773025A (en) * 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
US6726930B1 (en) 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5543099A (en) * 1994-09-29 1996-08-06 Hallmark Pharmaceutical, Inc. Process to manufacture micronized nifedipine granules for sustained release medicaments
DE59410044D1 (de) * 1994-12-29 2002-03-21 Shire Deutschland Gmbh & Co Kg Pharmazeutische zubereitungen, enthaltend nifedipin und verfahren zu ihrer herstellung
JP3220373B2 (ja) 1995-11-28 2001-10-22 バイエル薬品株式会社 持続性ニフエジピン製剤
AU695734B2 (en) 1996-07-08 1998-08-20 Penwest Pharmaceuticals Co. Sustained release matrix for high-dose insoluble drugs
IT1284604B1 (it) * 1996-09-27 1998-05-21 Roberto Valducci Composizioni farmaceutiche a rilascio controllato per somministrazione orale contenenti nifedipina come sostanza attiva
US6056977A (en) 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
WO2001022940A1 (en) 1999-09-30 2001-04-05 Edward Mendell Co., Inc. Sustained release matrix systems for highly soluble drugs
RU2378272C2 (ru) 2004-07-30 2010-01-10 Торрент Фармасьютикалз Лимитед Небиволол и его фармацевтически приемлемые соли, способ их получения и фармацевтические композиции небиволола
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3330727A (en) * 1960-04-19 1967-07-11 Glaxo Lab Ltd Griseofulvin with high specific surface area
US3401221A (en) * 1964-08-25 1968-09-10 Norwich Pharma Co Treatment of urinary tract infection
DE2348334C2 (de) * 1973-09-26 1982-11-11 Boehringer Mannheim Gmbh, 6800 Mannheim Neue Zubereitungsform des N-4-[2-(5-Chlor-2-methoxybenzamido)äthyl]- phenyl-sulfonyl-N'-cyclohexylharnstoffs
DE2400819C2 (de) * 1974-01-09 1982-04-22 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung fester Zubereitungen von schwerlöslichen Arzneimittelwirkstoffen in feinster Verteilung
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
JPS55129221A (en) * 1979-03-29 1980-10-06 Kaken Pharmaceut Co Ltd Preparation of oral preparation containing hardly soluble medicine
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material

Also Published As

Publication number Publication date
IL63749A0 (en) 1981-12-31
IE51549B1 (en) 1987-01-07
CA1180277A (en) 1985-01-02
IE812075L (en) 1982-03-09
FI812758L (fi) 1982-03-10
PL232951A1 (da) 1982-10-11
GR78237B (da) 1984-09-26
DK154326B (da) 1988-11-07
NZ198285A (en) 1984-04-27
DE3033919A1 (de) 1982-04-22
NO812879L (no) 1982-03-10
PT73603A (en) 1981-09-01
JPS5750913A (en) 1982-03-25
NO157368B (no) 1987-11-30
FI72648B (fi) 1987-03-31
PH24097A (en) 1990-03-05
DE3161838D1 (en) 1984-02-09
AU558331B2 (en) 1987-01-29
JPS5914446B2 (ja) 1984-04-04
PT73603B (en) 1982-11-10
IL63749A (en) 1984-06-29
DD201974A5 (de) 1983-08-24
EP0047899B1 (de) 1984-01-04
AU7506381A (en) 1982-03-18
EP0047899B2 (de) 1996-02-28
EP0047899A1 (de) 1982-03-24
DK154326C (da) 1995-03-13
HU184879B (en) 1984-10-29
ZA816213B (en) 1982-09-29
AR226377A1 (es) 1982-06-30
ATE5761T1 (de) 1984-01-15

Similar Documents

Publication Publication Date Title
DK396381A (da) Faste laegemiddelpraeparater og fremgangsmaade til deres fremstilling
DK211084A (da) Hurtigtoploesende laegemiddelpraeparater og fremgangsmaade til fremstilling heraf
DK162445C (da) Pyranopyridiner, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende pyranopyridinerne
DK66988D0 (da) Cholestyraminpraeparat og fremgangsmaade til fremstilling deraf
DK288184D0 (da) 13alfa-alkylgonaner, deres fremstilling og farmaceutiske praeparater indeholdende disse
DK33580A (da) Stabilt prostaglandin-indehldende praeparat og fremgangsmaade til fremstilling deraf
DK446982A (da) Cyanosteroider og fremgangsmaade til deres fremstilling
NO822671L (no) Farmasoeytisk virksomme forbindelser og fremgangsmaate for deres fremstilling.
DK166583C (da) 1-pyrimidinyloxy-3-alkylamino-2-propanoler, deres fremstilling og farmaceutiske praeparater indeholdende disse
DK48482A (da) Azopigmentpraeparater,fremgangsmaade til deres fremstilling og deres anvendelse
DK306982A (da) Aerosol-praeparater paa vmadbasis og fremgangsmaade til deres fremstilling
DK401882A (da) Cyclopentadienderivater og fremgangsmaader til deres fremstilling
DK251281A (da) N6-adenosiner og fremgangsmaader til deres fremstilling
DK329985D0 (da) Antitumor-farmaceutiske midler og fremgangsmaade til deres fremstilling
DK165336C (da) Koncentrerede stofbloedgoerende midler og fremgangsmaader til deres fremstilling
DK488385D0 (da) N6-bicycloadenosinforbindelser, deres fremstilling og farmaceutiske praeparater indeholdende saadanne forbindelser
DK415388A (da) Farmaceutiske praeparater indeholdende pyrimidinderivater og fremgangsmaade til fremstilling deraf
DK261485A (da) Kosmetiske praeparater og fremgangsmaade til deres fremstilling
NO824312L (no) 4-cyano-2-azetidinoner og fremgangsmaate for deres fremstilling
DK228185D0 (da) Nifedipinpraeparater og fremgangsmaader til deres fremstilling
DK47681A (da) Fremgangsmaade til fremstilling af farmaceutiske praeparater
DK528481A (da) Bis-hydroxybenzylderivater fremgangsmaader til deres fremstilling og farmaceutiske praeparater indeholdende dem
DK228085A (da) Nifedipinkombinationspraeparater og fremgangsmaader til deres fremstilling
DK332782A (da) 2-cyanosteroider og fremgangsmaade til deres fremstilling
DK701588D0 (da) N-hydroxy-5-phenyl-2-furancarboximidamider og anvendelse heraf til fremstilling af farmceutiske praeparater

Legal Events

Date Code Title Description
PUP Patent expired